Skip to main content
. 2020 Jul 3;10:10999. doi: 10.1038/s41598-020-67929-z

Figure 1.

Figure 1

Schematic representation of the workflow of plasma proteomic analysis. The study schema is illustrated with the patient populations and methods used. Plasma protein biomarker discovery (N = 8) was guided by plasma‐based proteomics followed by 2D-DIGE mass spectrometry. Selected protein candidates were validated in an independent cohort (N = 28) by western blotting analysis.